AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04791475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adding Dexmedetomidine and dexamethasone to bupivacaine in USG guided supraclavicular brachial plexus block.
Description: The linear transducer probe (frequency 4 -12 Hz) of USG machine will be used. A superficial skin wheal will be made by 2ml of 1% lignocaine subcutaneously at the point of needle insertion. USG guided Brachial plexus block will be performed by supraclavicular route via the subclavian perivascular approach in in-plane technique from lateral to medial using 22 gauge spinal needle. Study Drug will be administered via Pressure Monitoring line connected to syringe according to the allocated group with repeated aspiration and incremental dosing. • Intercostobrachial nerve block will be performed to alleviate the tourniquet pain. A 25 G needle will be inserted at the level of axillary fossa. The entire width of the medial aspect of arm, starting at the deltoid prominence and proceeding inferiorly, will be infiltrated with 5ml of 1% Lignocaine with Epinephrine (1:4,00,000) to raise a subcutaneous wheal. •
Study NCT05213143 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurasidone
Description: Lurasidone was oral administrated with a meal or within 30 min after eating in the evening. The maintenance dose of olanzapine from Day 0 to Day 6, than tapered until discontinuation from Day 7 to Day 27. Lurasidone initiated with 40mg/d on Day 0, maintained until Day 13, with a flexible dose (40-80mg/d, qd) from Day 28 to Day 111.
Study NCT06204211 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ophthalmologic examinations
Description: All the included personnel underwent routine ophthalmologic examinations on binoculus, including slit lamp microscope observation, intraocular pressure, diopters of refractive error, best corrected visual acuity, AL measurement, fundus photography and optical coherence tomography, adhering to the established and normalized principles.
Study NCT06270667 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined Aerobic and Resistance Exercise
Description: Twice weekly, supervised combined aerobic and resistance exercise sessions will be offered to participants. Participants randomized to the combined aerobic and resistance training group will follow the same aerobic exercise prescription as described for the Aerobic Exercise arm. In addition, participants in this group will perform five resistance exercises after the aerobic sessions. The resistance exercises will be leg press, knee extension, and calf rise, followed by seated row and chest press. Following familiarization, the training load will progressively increase following a linear periodization model throughout the intervention. exercise prescription will be sequenced so that the exercise intensity and -duration of each exercise varies within each week, leading to an accumulative increase in weekly exercise volume throughout the intervention. Only Lymphoma participants can be randomized to this arm.
Study NCT06042530 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological investigation
Description: Comprehensive neuropsychological test battery covering logical reasoning, different attention functions, executive functions, visuospatial functions, different memory functions, psychomotor speed, motor functions, and smell identification
Study NCT06042530 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Optometric investigation
Description: Extended vision examination including symptom assessment, visual acuity, visual field (confrontation), eye movements, eye teaming and clinical assessment of hypersensitivity to visual stimuli.
Study NCT06042530 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: The MRI sequence protocol includes resting state fMRI before and after the participants do an established 20 min long reaction time measurement paradigm (E-prime). During the paradigm a pseudo-continious arterial spin labeling sequence (pCASL) is acquired for continuous measurement of brain perfusion. Following the functional sequences the imaging protocol also includes a high resolution 3D T1weighted sequence Magnetization Prepared Rapid Gradient Echo (MPRAGE) for brain structure, a high resolution 3D T2-weighted sequence Fluid-Attenuated Inversion Recovery (FLAIR) for pathology and a 3D susceptibility weighted image (SWI) for microvascular abnormalities.
Study NCT06042530 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Immunological biomarkers
Description: Venous blood samples (10-20 ml) are taken from the elbow crease. They are drawn in the morning, and the participants are asked to fast for 12 hours prior to sampling. They are also asked to avoid physical activity prior to blood sampling. The samples are drawn into citrated tubes.
Study NCT05473104 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Program for the Education and Enrichment of Relational Skills
Description: Social training targeting adolescents with ASD and focused on making and keeping friends
Study NCT04670198 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Empowerment Skills
Description: The Youth Empowerment Skills (YES) programme is a novel psychoeducational intervention with simulation-based experiential learning tailored to the needs of young people. It is based on a social-cognitive learning model, and comprises attendance at 3 all-day YES sessions in non-healthcare settings (groups of 10); and then post-programme networking through social media and follow-up events facilitated by the youth worker. Sessions are led by a peer-educator and a health professional
Study NCT04670198 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waiting-list control
Description: Usual care for 6 months, followed by the YES programme.
Study NCT05875363 — intervention group
Intervention type: OTHER
Intervention: collect data
Description: The Juvenile Affairs Division provided the records without person-identifiable data (i.e., name, ID) to the researchers. The researchers coded the above data (i.e., the offenders' sociodemographic data, medical history, and criminal history).~Demographic characteristics were collected, which are the offenders' age, gender, occupation, education level, and residence (district). We recorded the offenders' household members (without the name or age), main caregivers (e.g., father, or mother), and the parents' socioeconomic and marital status. We also tracked whether the offenders live with family members with mental illness, whether they are from at-risk families, and whether had been victims of domestic violence. The medical history and deviant (or criminal) behaviors will be collected in the attached measure.
Study NCT04380623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Phone-Based Web-Page: HPV vaccine
Description: Website to be accessed via mobile phone to deliver tailored educational material
Study NCT05451186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eye patch and headphones
Description: Patients in the experimental group will be asked to use an eye mask and earplugs from 22:30 to 6:30 in the morning on the 1st, 2nd and 3rd nights.
Study NCT04380623 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile Phone-Based Web-Page: HPV vaccine
Description: Website to be accessed via mobile phone to deliver tailored educational material
Study NCT05367193 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pars plana vitrectomy
Description: pars plana vitrectomy for vitreoretinal disease in highly myopic eyes
Study NCT05367193 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pars plana vitrectomy
Description: pars plana vitrectomy for vitreoretinal disease in highly myopic eyes
Study NCT05363449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UHE-103 Cream
Description: UHE-103 is an investigational combinational therapy containing keratolytic and antifungal
Study NCT05363449 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naftin (naftifine hydrochloride) Cream
Description: Naftin (naftifine hydrochloride) Cream, 2%. Topical cream containing active drug
Study NCT05367193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NGENUITY® 3D Visualization System (Alcon, TX, USA)
Description: Injection of ICG to stain internal limiting membrane
Study NCT01078792 — intervention group
Intervention type: OTHER
Intervention: CT pulmonary angio, blood tests
Study NCT05390918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAILOR
Description: The first TAILOR session will assess existing sleep problems from both the adolescent's and parent/legal guardian's perspectives, concluding with offering a CBT strategy to try. Session 2 will involve getting feedback from the family on that specific strategy and then offering additional CBT strategies. The remaining sessions will be devoted to refining the use of CBT strategies. MI will be integrated as the communication style throughout, including reflective listening, rolling with resistance, and showing deference to the family's ultimate decisions. The interventionist will also use the elicit-provide-elicit approach from MI. The interventionist will elicit the family's own ideas for improving the adolescent's sleep, ask for permission to provide his/her own suggestions, and then gauge the family's reactions to those suggestions, versus simply recommending a CBT strategy and problem-solving barriers to implementation.
Study NCT05390918 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Enhanced Usual Care
Description: The study clinician will conduct suicide risk screening and further assessment and safety planning where deemed necessary.
Study NCT05042115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education in pain neurosciences and clinical hypnosis
Description: Will be performed education in pain neurosciences and clinical hypnosis, in 4 sessions during 4 weeks
Study NCT05042115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education in pain neurosciences and clinical hypnosis plus osteopathic manipulative treatment
Description: Will be performed education in pain neurosciences and clinical hypnosis, and only for this group will be delivered osteopathic manipulative treatment, in 4 sessions during 4 weeks
Study NCT06504914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assigned Interventions
Description: Behavioral: RN-CHeFRx The RN-CHeFRx trial to enhance dietary intake and blood pressure control in Black women with hypertension and obesity compared to usual care.
Study NCT05496530 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suprachoroidal triamcinolone acetonide injection
Description: Pars plana suprachoroidal injection of 4mg//0.1ml triamcinolone acetonide.
Study NCT04637230 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram analysis by Artificial Intelligence
Description: 1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Study NCT05595850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Online non-meditation mindfulness program
Study NCT05406557 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Partial pulpotomy
Description: In case of partial pulpotomy procedure the exposed pulp tissue will be amputated using a sterile bur in the high speed hand piece with water coolant to a depth of superficial 2-3 mm of pulp chamber.
Study NCT05406557 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Miniature pulpotomy
Description: In case of miniature pulpotomy procedure the exposed pulp tissue will be amputated using a sterile bur in the high speed hand piece with water coolant to a depth of superficial 2-3 mm of only affected pulp horn
Study NCT05595850 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindful Learning
Description: Online learning program
Study NCT04858438 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insufflation during surgery
Description: This is the amount of insufflation using during the surgical procedure.
Study NCT04858438 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Insufflation during surgery
Description: This is the amount of insufflation using during the surgical procedure.
Study NCT04861779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK29116
Description: Oral HSK29116
Study NCT04498520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abexinostat Tosylate
Description: Given PO
Study NCT04498520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Given IM
Study NCT05599698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Standard chemotherapy protocols for adjuvant \& neoadjuvant treatment for different types of solid malignancies
Study NCT04498520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Given PO
Study NCT05374369 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: SDC2 Gene Methylation Test and Q-FIT Test
Description: Stool specimens were collected by the subjects for SDC2 Gene Methylation Test and Q-FIT Test
Study NCT05102513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unilateral Cleft Lip Repair: Hybrid Technique
Description: The rotation flap of the Millard II technique was expanded by extending the incision into the columella - similar to the well-known Mohler technique. The caudal part of the advancement flap of the Millard II technique was lengthened by a wave cut as known from the Pfeiffer procedure. For the vermillion a Noordhoff plasty is applied.
Study NCT05102513 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unilateral Cleft Lip Repair: Millard 2 Technique
Description: A curved incision is marked skirting the philtral ridge. If more length is required a back-cut incision can be performed. The C-flap is outlined by the incision just marked and the incision along red-white border up to the base of the columella. On the cleft side an advancement flap is designed. For the vermillion a Noordhoff plasty is applied.
Study NCT05482035 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: wrist blood pressure monitor
Description: Comparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer .
Study NCT05374369 — intervention group
Intervention type: PROCEDURE
Intervention: Colonoscopy and/or pathological examination
Description: Subjects underwent colonoscopy and/or pathological examination.
Study NCT04263779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Order of Options
Description: Relevant providers who are part of the Geisinger preferred provider network will be presented at the top of the otherwise ranked list of SNFs.
Study NCT04263779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Default Option
Description: Both the list and the map will present only the P-SNFs, with a button allowing patients to view all results only if they opt to do so. The optional P-SNF advantage video will be included and the link to it highlighted.
Study NCT04859972 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of IBS
Description: Diagnosis of IBS according to ICD-10
Study NCT05419271 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: home hemodialysis session with 9L internal convection
Description: home hemodialysis session with 9L internal convection
Study NCT05064332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06650833
Description: 400 mg by mouth (PO) Once daily (QD) for 11 days
Study NCT05064332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (EE) and levonogestrel (LN)
Description: Single dose of Oral tablet containing 30 ug EE and 150 ug of LN
Study NCT05698043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(5)
Description: Test
Study NCT05698043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: Reference
Study NCT05622344 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Therapy
Description: Exercises that teaches subjects to move their heads while viewing still or moving targets.
Study NCT05622344 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SWAN
Description: The SWAN device uses video-oculography to monitor head motion while guiding participants to move their head in yaw, pitch, roll planes for 15 minutes. Feedback is provided regarding frequency and plane of head rotation
Study NCT04696237 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: a questionnaire to provide data about the management of cleft lip and palate patients in Egypt will be designed
Study NCT04967066 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum Levels of Adipocytokines
Description: Serum leptin and adiponectin: venous blood samples (3 ml) will be obtained from children with FS (within 3 hours of seizures) as well as the two control groups. The serum will be obtained by centrifugation at 3,500 rpm for 5 min at 4 ℃. The serum will be immediately separated and stored at -70 ℃. Serum leptin and adiponectin will be assessed through enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions.
Study NCT06152406 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ablation and Pacemaker Implantation
Description: All patients will be implanted with a pacemaker device with one lead positioned in right ventricle (control arm only) and an additional lead will be positioned on the distal (ventricular) HIS bundle if in intervention arm. All patients will undergo ablation.
Study NCT06152406 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ablation and Pacemaker Implantation
Description: All patients will be implanted with a pacemaker device with one lead positioned in right ventricle (control arm only) and an additional lead will be positioned on the distal (ventricular) HIS bundle if in intervention arm. All patients will undergo ablation.
Study NCT05259878 — intervention group
Intervention type: OTHER
Intervention: Adverse Childhood Events
Description: • The Adverse Childhood Events (ACE) scale is a validated 10-item binary questionnaire (yes or no) that retrospectively measures domains of physical, emotional, and sexual abuse in the first 18 years of life. Scores range from 0 to 10 with higher scores indicating more adverse experiences during patients' childhood.
Study NCT06446180 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SsK12@Lip@GSH
Description: SsK12@Lip@GSH powder contained no less than 5×10\^8 CFU viable cells of SsK12@Lip@GSH as the active ingredient.
Study NCT05949671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mediterranean, gluten-free and mediterranean gluten-free diet intervention
Description: This study is a prospective, single-blind study including case and control groups. Before the study started, participants were informed about the benefits and risks of the study. Participants were randomly divided into four different groups (MD, GFD, MGFD and control group). The intervention groups (MD group (n=10), GFD (n=10), MGFD (n=10)) were administered weekly diets by a dietitian for 12 weeks according to individual-specific and daily energy needs and weight loss was not targeted. Patients in the control group (n=10) did not receive any special dietary intervention. Patients were interviewed weekly to assess adherence to the study protocol and food consumption was recorded at each interview; those who complied with the weekly planned menus by less than eighty percent were excluded from the study.
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyronaridine Tetraphosphate
Description: A total of 24 participants will be dosed with pyronaridine tetraphosphate, sixteen participants will be additionally be dosed with piperaquine tetraphosphate, eight patients will additionally be dosed with placebo.
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pyronaridine Tetraphosphate
Description: A total of 24 participants will be dosed with pyronaridine tetraphosphate, sixteen participants will be additionally be dosed with piperaquine tetraphosphate, eight patients will additionally be dosed with placebo.
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Piperaquine tetraphosphate
Description: A total of 24 participants will be dosed with piperaquine tetraphosphate, sixteen participants will be additionally be dosed with pyronaridine tetraphosphate, eight patients will additionally be dosed with placebo.
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperaquine tetraphosphate
Description: A total of 24 participants will be dosed with piperaquine tetraphosphate, sixteen participants will be additionally be dosed with pyronaridine tetraphosphate, eight patients will additionally be dosed with placebo.
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets will be administered in combination with pyronaridine tetraphosphate (8 patients), OR, in combination with piperaquine tetraphosphate (8 patients), OR, only matched placebo tablets will be administered (8 patients)
Study NCT05160363 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: Placebo tablets will be administered in combination with pyronaridine tetraphosphate (8 patients), OR, in combination with piperaquine tetraphosphate (8 patients), OR, only matched placebo tablets will be administered (8 patients)
Study NCT05298943 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: walking in 4 situations
Description: Recording of cerebral hemodynamic with fNIRS during gait in exoskeleton with Four strength levels of aid : total aid (A100%), partial aid (A50%), no aid (A0%) and resistance of 25 % (R25%) to walking from the exoskeleton. Each subject are recorded during 8 trials for each level (32 trials). The order is counterbalanced among the subjects
Study NCT05624983 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: acoustic otoemisions
Description: TOAE and DPOAE
Study NCT05624983 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: acoustic otoemisions
Description: TOAE and DPOAE